Try our Advanced Search for more refined results
Immunex Corporation v. Sanofi-Aventis U.S. LLC
Case Number:
19-1749
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
October 13, 2020
Fed. Circ. Backs Sanofi, Regeneron PTAB Win Over Amgen
The Federal Circuit on Tuesday upheld a Patent Trial and Appeal Board decision invalidating an Amgen unit's patent on treating inflammatory disorders, in a win for Sanofi and Regeneron, whose eczema and asthma treatment Dupixent was accused of infringement.
-
August 05, 2020
Immunex Faces Skeptical Fed. Circ. In Antibody Patent Fight
A Federal Circuit panel appeared skeptical Wednesday that the Patent Trial and Appeal Board ignored vital evidence in construing a key claim term to invalidate an Immunex antibody patent at the behest of Sanofi-Aventis, suggesting that evidence supports the board's claim construction.